Major Depression in Remission
10
0
2
5
Key Insights
Highlights
Success Rate
83% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
10.0%
1 terminated out of 10 trials
83.3%
-3.2% vs benchmark
0%
0 trials in Phase 3/4
20%
1 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (10)
Pharmaco-Neuroimaging Studies of Approach/Avoidance Behaviors and Post-Mortem Studies: Study 1.2 (Stress Manipulation)
Predicting Illness Trajectories In Fully Remitted Major Depression Using Concurrent TBS/fNIRS
Internet-delivered Intervention Targeting Residual Cognitive Symptoms After Major Depressive Disorder
Feasibility of Adherence to Light Therapy
Optimal Dose of a Cognitive Control Training for Depression Vulnerability
Effects of Booster Sessions on Depression Vulnerability Following Cognitive Control Training
Online Contingent Attention Training (OCAT)
Online Cognitive Control Training for Remitted Depressed Patients
Investigating the Mechanisms of Mindfulness-based Cognitive Therapy (MBCT)
Cognitive Control Training for Remitted Depressed Patients